Internet Archive Scholar

Endothelial Progenitor Cells as Pathogenetic and Diagnostic Factors, and Potential Targets for GLP-1 in Combination with Metabolic Syndrome and Chronic Obstructive Pulmonary Disease

Evgenii Skurikhin, Olga Pershina, Angelina Pakhomova, Edgar Pan, Vyacheslav Krupin, Natalia Ermakova, Olga Vaizova, Anna Pozdeeva, Mariia Zhukova, Viktoriia Skurikhina, Wolf-Dieter Grimm, Alexander Dygai
2019 International Journal of Molecular Sciences  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (2.5 MB)
https://web.archive.org/web/20190504035816/https://res.mdpi.com/ijms/ijms-20-01105/article_deploy/ijms-20-01105-v3.pdf?filename=&attachment=1

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL. The file type is application/pdf.

In clinical practice, there are patients with a combination of metabolic syndrome (MS) and chronic obstructive pulmonary disease (COPD). The pathological mechanisms linking MS and COPD are largely unknown. It remains unclear whether the effect of MS (possible obesity) has a major impact on the progression of COPD. This complicates the development of effective approaches for the treatment of patients with a diagnosis of MS and COPD. Experiments were performed on female C57BL/6 mice. Introduction
more » ... of monosodium glutamate and extract of cigarette smoke was modeled to simulate the combined pathology of lipid disorders and emphysema. Biological effects of glucagon-like peptide 1 (GLP-1) and GLP-1 on endothelial progenitor cells (EPC) in vitro and in vivo were evaluated. Histological, immunohistochemical methods, biochemical methods, cytometric analysis of markers identifying EPC were used in the study. The CD31+ endothelial cells in vitro evaluation was produced by Flow Cytometry and Image Processing of each well with a Cytation™ 3. GLP-1 reduces the area of emphysema and increases the number of CD31+ endothelial cells in the lungs of mice in conditions of dyslipidemia and damage to alveolar tissue of cigarette smoke extract. The regenerative effects of GLP-1 are caused by a decrease in inflammation, a positive effect on lipid metabolism and glucose metabolism. EPC are proposed as pathogenetic and diagnostic markers of endothelial disorders in combination of MS with COPD. Based on GLP-1, it is proposed to create a drug to stimulate the regeneration of endothelium damaged in MS and COPD.
doi:10.3390/ijms20051105 fatcat:zmybi3qlcrehnldypko7qfrhlm
DOAJ
Citation

Evgenii Skurikhin, Olga Pershina, Angelina Pakhomova, Edgar Pan, Vyacheslav Krupin, Natalia Ermakova, Olga Vaizova, Anna Pozdeeva, Mariia Zhukova, Viktoriia Skurikhina, Wolf-Dieter Grimm, Alexander Dygai. "Endothelial Progenitor Cells as Pathogenetic and Diagnostic Factors, and Potential Targets for GLP-1 in Combination with Metabolic Syndrome and Chronic Obstructive Pulmonary Disease." International Journal of Molecular Sciences 20.5 (2019) 1105